Illegal psychoactive substances and illicit prescription drugs are currently used on a daily basis all over the world. Affecting public health and social welfare, illicit drug use is linked to disease, disability, and social problems. Faced with an increase in usage, national and global policymakers are turning to addiction science for guidance on how to create evidence-based drug policy. Drug Policy and the Public Good is an objective analytical basis on which to build global drug policies. It presents the accumulated scientific knowledge on drug use in relation to policy development on a national and international level. By also revealing new epidemiological data on the global dimensions of drug misuse, it questions existing regulations and highlights the growing need for evidence-based, realistic, and coordinated drug policy. A critical review of cumulative scientific evidence, Drug Policy and the Public Good discusses four areas of drug policy; primary prevention programs in schools and other settings; supply reduction programs, including legal enforcement and drug interdiction; treatment interventions and harm reduction approaches; and control of the legal market through prescription drug regimes. In addition, it analyses the current state of global drug policy, and advocates improvements in the drafting of public health policy. Drug Policy and the Public Good is a global source of information and inspiration for policymakers involved in public health and social welfare. Presenting new research on illicit and prescription drug use, it is also an essential tool for academics, and a significant contribution to the translation of addiction research into effective drug policy.

This comparative history examines the divergent paths taken by Britain and France in managing opiate abuse during the late nineteenth and early twentieth centuries. Though the governments of both nations viewed rising levels of opiate use as a problem, Britain and France took opposite courses of action in addressing the issue. The British sanctioned maintenance treatment for addiction, while the French authorities did not hesitate to take legal action against addicts and the doctors who prescribed drugs to them. Drawing on primary documents, Howard Padwa examines the factors that led to these disparate approaches. He finds that national policies were influenced by shifts in the composition of drug-using populations of the two countries and a marked divergence in British and French conceptions of citizenship. Beyond shared concerns about public health and morality, Britain and France had different understandings of the threat that opiate abuse posed to their respective communities. Padwa traces the evolution of thinking on the matter in both countries, explaining why Britain took a less adversarial approach to domestic opiate abuse despite the productivity-sapping powers of this social poison, and why the relatively libertine French chose to attack opiate abuse. In the process, Padwa reveals the confluence of changes in medical knowledge, culture, politics, and drug-user demographics throughout the period, a convergence of forces that at once highlighted the issue and transformed it from one of individual health into a societal concern. An insightful look at the development of drug discourses in the nineteenth century and drug policy in the twentieth century, Social Poison will appeal to scholars and students in public health and the history of medicine.

This book examines the topical issue of global drug policy and outlines five steps that could be taken to improve its effectiveness. A public criminology approach is applied to explore not only what could be done, but also why it matters and how it could be achieved. It argues that more effective global drug policies require an acknowledgement of the failure of a war on drugs approach and the harms it has caused. Instead, strategies that reduce drug related harm should be prioritised. An innovative and diverse range of approaches should be developed that are underpinned by evaluation and dissemination of results. Finally, the horizons of the drug policy debate should be broadened. In line with the central aims of public criminology, this book provides an accessible contribution to global drug policy debates that links theory and practice and which will have appeal to a wide range of audiences.

While evidence-based policy is an emerging rhetoric of the desire by and for governments to develop policies based on the best available evidence, drug policy is an area where particular challenges abound. This book is a detailed and comprehensive examination of the contours of drug policy development through the consideration of the particular roles of science, media, and interest groups. Using Belgium as the primary case-study, supplemented by insights gathered from other countries, the author contributes to a richer understanding of the science-policy nexus in the messy, real-world complexities of drug policy. Change or Continuity in Drug Policy: The Roles of Science, Media, and Interest Groups is the first book to bring together policy and media theories, knowledge utilisation models, and public scholarship literature. As such, the book provides unique insights relevant to aspects of change or continuity in drug policies in Europe and beyond. This book will be of great value to undergraduate and graduate students, as well as to academics, practitioners and policymakers with interest in the science-policy nexus with a particular focus on the drug policy domain.

The US-led war on drugs has failed: drugs remain purer, cheaper and more readily available than ever. Extreme levels of violence have also grown as drug traffickers and organized criminals compete for control of territory. This book points towards a number of crucial challenges, policy solutions and alternatives to the current drug strategies.

For half a century the Misuse of Drugs Act 1971 has dominated ill-conceived approaches to the prohibition of drugs and the criminalisation of many offenders. Wilful blindness to scientific facts has distorted the dispensation of justice, prevented lifesaving investigation, sidelined critics and thwarted advocates of politically inconvenient drugs law reform. This once in an epoch review by experts from a range of disciplines, Drug Science and British Drug Policy shows how lawmakers and the media have ignored the scientific evidence to sustain badly founded rhetoric in favour of blanket bans, punishment and the marginalisation of opponents. Countless individuals (including the vulnerable, deprived, addicted and mentally ill) have therefore suffered unnecessarily. This, the most comprehensive critique of the 1971 Act yet, rests on the combined learning of leading medical, scientific, psychiatric, academic, legal, drug safety and other specialists to provide sound reasons to re-think half a century of bad law. A thorough examination of the 1971 Act which challenges long outmoded ideas. Demonstrating political and media distortions the book calls for fresh thinking and urgent reform. Drug Science and British Drug Policy is first-rate, in-depth and highly informed. Review ‘It is time to see the MDA 1971 for what it is: a bad law that has the opposite effect to that intended. The so-called war on drugs is lost. It could never be won. Let us replace this knee-jerk law with something rational, something evidence-based, something more humane.’— Rt Hon Norman Baker (From the Foreword).

Debate around drugs and the policies, taxes, and regulations that surround them have left citizens and officials with questions on what can be done about both illicit drugs and marijuana. The foremost public and scholarly authorities on U.S. drug policy provide a truly balanced and comprehensive overview of the subject in this bundle containing Drugs and Drug Policy: What Everyone Needs to Know and Marijuana Legalization: What Everyone Needs to Know.

The multifaceted nature of harmful substance use and gambling requires interdisciplinary analysis to assess the underlying causes. What Determines Harm from Addictive Substances and Behaviours? draws together evidence from twelve disciplines including anthropology, genetics, neurobiology, and public policy. Using a developmental approach, the book presents evidence on the factors that influence the development of harmful substance use and gambling. The determinants of harm operate at three levels: molecular, individual, and social. This book brings to light the complex interplay between them and presents the scientific, social, economic, political, and psychological influences of harmful substance use and gambling. These individual determinants are then synthesised into an integrative heuristic model to encourage new ways of thinking. The findings from this analysis are used to elaborate key general implications for health and broader social policy, clinical practice, and future research. What Determines Harm from Addictive Substances and Behaviours? is based on research from ALICE RAP, a multidisciplinary European study of addictive substances and behaviours in contemporary society. This is an essential resource for public health professionals, stakeholders influencing policy for addictive substances and behaviours, students, and academics looking to better understand the factors influencing substance use and gambling and the implications this research has for addiction prevention policy.

Analysing arguably one of the most controversial areas in public policy, this pioneering Research Handbook brings together contributions from expert researchers to provide a global overview of the shifting dynamics of drug policy. Emphasising connections between the domestic and the international, contributors illustrate the intersections between drug policy, human rights obligations and the 2030 Sustainable Development Agenda, offering an insightful analysis of the regional dynamics of drug control and the contemporary and emerging problems it is facing.

In A-to-Z format and spanning two volumes of 450 entries, this encyclopedia covers all aspects of drug policy through a variety of disciplines including criminology, sociology, psychology and politics.